Top 50 Silverarc Capital Management, Llc Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| KALV | KALVISTA PHARMACEUTICALS INC | 6.82% | 2.88M | $57.9M | +18.51%(+449.29K) | $13.04(+105.05%) | 2026-03-31 | |
| DNTH | DIANTHUS THERAPEUTICS INC | 6.47% | 654.7K | $54.9M | -12.72%(-95.39K) | $28.97(+225.65%) | 2026-03-31 | |
| COGT | COGENT BIOSCIENCES INC | 5.96% | 1.31M | $50.6M | +5.54%(+68.94K) | $15.75(+145.66%) | 2026-03-31 | |
| CELC | CELCUITY INC | 4.81% | 357.9K | $40.9M | -4.59%(-17.23K) | $64.36(+67.73%) | 2026-03-31 | |
| IMNM | IMMUNOME INC | 4.77% | 1.85M | $40.5M | +64.29%(+724.07K) | $18.58(+27.05%) | 2026-03-31 | |
| KOD | KODIAK SCIENCES INC | 4.46% | 991.9K | $37.8M | -3.05%(-31.19K) | $8.46(+355.67%) | 2026-03-31 | |
| NUVL | NUVALENT INC | 4.28% | 354.9K | $36.4M | +13.96%(+43.48K) | $75.12(+64.70%) | 2026-03-31 | |
| ABVX | ABIVAX SA | 3.97% | 302.5K | $33.7M | -28.34%(-119.66K) | $33.48(+332.02%) | 2026-03-31 | |
| GLUE | MONTE ROSA THERAPEUTICS INC | 3.88% | 2.00M | $32.9M | +94.55%(+972.97K) | $11.80(+105.12%) | 2026-03-31 | |
| ERAS | ERASCA INC | 3.53% | 1.85M | $30.0M | +40.55%(+534.23K) | $4.46(+313.77%) | 2026-03-31 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative |
|---|---|---|
| Top 20 Holdings Weighted | +5.48% | +17.36% |
| Top 20 Holdings Unweighted | +1.72% | +5.25% |
Sign up free to track Silverarc Capital Management, Llc, compare funds side by side, and get alerts the moment positions change.